TLSI · ISSUER CIK 1826667
TriSalus Life Sciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 TriSalus Life Sciences, Inc. insiders reported $0.00 of open-market purchases and $4K of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$4KInsider selling
−$4KNet open-market
Oct 7, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202616:02 | Oct 5, 2026 | TLSI | Chief of Research | S · Sell | $4.39 | −296 | 162,805 | -0% | −$1K | ||
| Oct 7, 202616:02 | Oct 5, 2026 | TLSI | Chief Commercial Officer | S · Sell | $4.39 | −325 | 127,994 | -0% | −$1K | ||
| Oct 7, 202616:02 | Oct 5, 2026 | TLSI | Chief Regulatory Officer | S · Sell | $4.39 | −316 | 123,794 | -0% | −$1K | ||
| Oct 7, 202616:02 | Oct 5, 2026 | TLSI | CEO and President, Director | F · Tax | $4.38 | −2,693 | 1,074,990 | -0% | $12K |